NCT05712473View on ClinicalTrials.gov

An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

June 30, 2029

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST

PYLARIFY

PYLARIFY PET

Sponsors

Collaborators (1)

Lantheus Medical Imaging

All Listed Sponsors

collaborator

Lantheus Medical Imaging

INDUSTRY

lead

Specialty Networks Research.

NETWORK